Post-Angioplasty Recovery Nutrition Market

How big is Post-Angioplasty Recovery Nutrition Market in 2026?

USD 119.1 million in 2026 and USD 262.0 million by 2036 at an 8.2% CAGR.

The post-angioplasty recovery nutrition market is projected to rise from USD 119.1 million in 2026 to USD 262.0 million by 2036 at an 8.2% CAGR. Cardiac rehabilitation gives clinicians an identifiable decision point before households execute most nutrition use after the procedure. In July 2025, Danone completed its majority acquisition of Kate Farms and placed that business beside Nutricia plus related clinical nutrition brands. The transaction expands access from hospital channels toward home use, which strengthens continuity for patients needing structured nutrition after revascularization.

Country-level conversion depends heavily on rehabilitation participation after the intervention and not on the global forecast alone. The British Heart Foundation noted in July 2025 that UK phase III cardiac rehabilitation uptake remained around 50%. That participation gap narrows the addressable specialized nutrition population despite formal eligibility, so commercial execution must follow local referral and fulfillment routes.

Key Takeaways

• Discharge-based cardiac rehabilitation gives nutrition providers a defined recommendation window before home recovery becomes less structured for recovering patients.
• Based on product type, cardiac recovery ONS is projected to account for 43.4% in 2026 due to standardized servings that simplify clinical handoff into home recovery.
• In 2026, the 0-30 days post-procedure phase is expected to lead the phase category with 51.0% share because discharge counseling concentrates new nutrition decisions early.
• By product form, prepared meals are forecast to represent 44.6% in 2026 driven by ready-to-heat portions that reduce shopping and cooking burden during early recovery.
• Evidence thresholds and uneven benefit coverage limit routine purchasing when a branded product offers little advantage beyond diet counseling.
• Some of the key players in this market include Abbott, Nestlé Health Science, Danone Nutricia, Mom's Meals (PurFoods), Step One Foods, ModifyHealth, Fresenius Kabi, and Medtrition.

Analyst Perspective

"Post-angioplasty nutrition becomes commercially durable when clinicians can place it inside the discharge plan without conflicting with sodium limits or ordinary food. Nutrition companies protect repeat revenue by pairing that clinical fit with a replenishment route patients can sustain at home once rehabilitation contact becomes less frequent."

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights

How is the post-angioplasty recovery nutrition market segmented?

The market is assessed by product type, phase, product form, end user and sales channel.

Market taxonomy covers product type, phase, product form, end user, sales channel and region for the 2026-2036 forecast. Product type includes cardiac recovery ONS, low-sodium discharge meal kits, omega-3 and polyphenol support plus other options for recovery nutrition. Phase separates 0-30 days, 1-6 months and long-term secondary prevention while product form covers prepared meals, RTD ONS, supplements and other formats. End users comprise homecare, cardiac rehab centers, hospitals and others while sales channels include hospital pharmacy, retail pharmacy, online, institutional tender and other routes.

What makes Cardiac Recovery ONS central to the Product Type category?

Cardiac recovery ONS gives dietitians a fixed serving that is easier to document than an improvised recovery diet. In May 2026 Abbott launched Ensure Strength Pro with 31 nutrients and 30 grams of protein per 100 grams, extending dense oral nutrition supplements available for structured intake.

• Based on product type, cardiac recovery ONS is projected to account for 43.4% in 2026 due to standardized servings that simplify clinical handoff into home recovery.
• Dense formulas remain useful during poor appetite, but clinicians need sodium and sugar profiles that fit the patient’s wider treatment plan during recovery.

Why does 0-30 Days Post-Procedure lead the Phase category?

The first month concentrates medication reconciliation with symptom review and rehabilitation referral, making nutrition instructions unusually actionable. Later phases face more competition from heart-health foods once patients resume shopping and meal preparation.

• By phase, the 0-30 days post-procedure segment is estimated to hold 51.0% in 2026 owing to concentrated discharge counseling and rehabilitation referral.
• The American Heart Association stated in February 2025 that outpatient cardiac rehabilitation referral before hospital discharge carries a Class 1 recommendation after acute coronary syndromes. That guidance places nutrition review beside discharge planning while product selection depends on patient-specific diet and tolerance.

How do Prepared Meals anchor the Product Form category?

Prepared meals translate sodium and portion guidance into a meal for patients who cannot shop or cook reliably. In June 2026 Mom's Meals and Agilix Health launched a pilot for up to 500 Medicare Advantage members pairing home-delivered meals with virtual nutrition care. The model gives therapeutic food delivery a defined continuation route for patients.

• The prepared meals segment is likely to capture 44.6% share in 2026 attributable to lower preparation burden during early home recovery.
• Ready-to-heat portions give dietitians a repeatable food format, although menu acceptance and benefit eligibility determine whether an initial order becomes regular use for recovering patients receiving dietetic follow-up.

What supports Homecare in the End User category?

Most eating decisions shift into the household soon after angioplasty, so homecare determines whether a discharge recommendation becomes repeat purchasing. Medical nutrition products need simple storage and clear instructions that fit medication and activity routines at home.

• The end user category is forecast to be led by homecare at 49.0% share in 2026 due to most daily nutrition decisions shifting home after discharge.
• AACVPR reported in April 2026 that virtual synchronous cardiac rehabilitation was extended until December 31, 2027 under federal legislation. That continuation preserves a reimbursable remote contact point while products require affordable replenishment once clinical sessions end.

What are the drivers, restraints and opportunities in the Post-Angioplasty Recovery Nutrition Market?

Structured secondary prevention increases nutrition demand while rehabilitation participation and product coverage constrain conversion, leaving home-linked fulfillment as the strongest expansion route.

• Driver: Recurrent coronary risk keeps diet review active during follow-up and gives structured nutrition a continuing role inside secondary prevention.
• Restraint: Low rehabilitation participation removes a key recommendation point before patients establish repeat meal and supplement routines at home.
• Opportunity: Hospital-to-home coordination gives clinically selected nutrition products a clearer route into repeat purchasing and documented follow-up.

Recurrent Coronary Risk Sustains Nutrition Review

Secondary prevention remains active because recurrent coronary complications can emerge well beyond the procedure itself. In March 2025 the American College of Cardiology reported that incident heart failure risk following myocardial infarction can be up to sixfold higher than recurrent infarction risk. That risk profile gives dietitians repeated opportunities to review intake during follow-up without implying that every patient needs a branded recovery product.

Low Rehabilitation Participation Narrows Conversion

Clinical eligibility does not guarantee cardiac rehabilitation attendance, which removes a key nutrition-review point for many recovering patients. In September 2025 the American Heart Association stated that fewer than 20% of eligible patients participate in cardiac rehabilitation. Transport and scheduling barriers leave nutrition companies dependent on separate outreach or household purchasing instead of a consistent clinical handoff into structured home recovery.

Hospital-to-Home Coordination Extends Revenue

Hospital teams preserve continuity when a nutrition recommendation reaches the home without forcing patients to rebuild the plan independently. Medtrition launched its NutriConnect modular-nutrition portfolio in October 2025 for individualized clinical support within documented nutrition protocols. Similar coordination lets medical foods and oral nutrition supplements follow a defined clinical need into replenishment instead of competing as generic heart-health purchases after discharge.

Which country CAGRs are profiled in the Post-Angioplasty Recovery Nutrition Market?

Country	CAGR
South Korea	8.3%
USA	7.8%
UK	7.5%
Germany	7.0%
Japan	6.5%

How do country-level CAGRs compare in the Post-Angioplasty Recovery Nutrition Market?

The five profiled CAGRs span 1.8 percentage points from South Korea at 8.3% to Japan at 6.5%. South Korea forms the fastest profile while USA and UK remain closely grouped. Germany and Japan form the slower pair, so local pathway access matters more for entry sequencing than small rate differences.

• South Korea ranks first as recurrent coronary burden sustains secondary-prevention counseling after discharge.
• USA follows because automated discharge referrals can improve entry into organized rehabilitation.
• UK growth depends on attendance converting commissioned rehabilitation access into sustained nutrition exposure.
• Germany reflects structured rehabilitation access and patient cost rules shaping outpatient continuation.
• Japan grows more slowly as clinician endorsement and local diet fit govern adoption.

Similar rates conceal different purchasing routes and benefit structures for commercial nutrition programs. The full report provides country-level CAGR analysis across North America, Latin America, Europe, East Asia, South Asia and Pacific and Middle East and Africa.

Country-wise Analysis

• South Korean hospitals manage substantial recurrent coronary disease, so recovery nutrition must fit secondary-prevention counseling and familiar household eating patterns following discharge. Demand for post-angioplasty recovery nutrition in South Korea is projected to grow at 8.3% CAGR through 2036 because hospital follow-up can extend diet review into home recovery. Korea Disease Control and Prevention Agency data released in December 2025 counted 34,768 myocardial infarction events during 2023. That disease burden keeps prevention work active during follow-up for older cardiac patients leaving hospital care. Culturally adapted meals and disciplined claims remain necessary before specialized nutrition becomes routine beside established Korean diets and rehabilitation advice.
• USA hospital systems increasingly place cardiac rehabilitation referrals inside electronic discharge workflows, giving dietitians a defined point to recommend structured nutrition following angioplasty. The American College of Cardiology noted in December 2025 that referral rates among Medicare beneficiaries remained below 25%. Low referral leaves many eligible patients outside organized follow-up, and nutrition reimbursement requires a separate benefit route beyond counseling. Demand for post-angioplasty recovery nutrition in USA is forecast to rise at 7.8% CAGR through 2036 aided by payer-linked rehabilitation. Companies gain the clearest route to repeat purchasing if discharge recommendations lead directly into covered home replenishment through USA oral nutrition channels.
• UK cardiac rehabilitation operates through commissioned service pathways, so nutrition exposure depends on actual programme entry following coronary intervention. The March 2026 National Audit of Cardiac Rehabilitation Quality and Outcomes Report recorded England acute coronary syndrome uptake at 44.5%. Post-angioplasty recovery nutrition demand in the UK is anticipated to advance at 7.5% CAGR through 2036 owing to formal rehabilitation access. Uneven participation leaves many eligible patients outside structured dietetic follow-up, which limits routine exposure for branded nutrition. Commercial offers fit best when they reinforce NHS diet guidance and practical home recovery without displacing ordinary food or existing rehabilitation services locally.
• German post-angioplasty recovery often moves from acute hospital treatment into structured rehabilitation, giving institutional diet standards unusual influence during early recovery. Germany is estimated to record 7.0% CAGR through 2036 given its rehabilitation infrastructure and established outpatient pathways. Deutsche Rentenversicherung stated in October 2025 that immediate post-hospital inpatient rehabilitation carries copay obligations for no more than 14 days, while outpatient rehabilitation has no copay. Branded meals and oral nutrition need their own continuation route because rehabilitation coverage does not automatically reimburse a product. Outpatient follow-up therefore offers a more practical commercial channel for sustained nutrition use once formal rehabilitation ends.
• Japanese cardiac rehabilitation relies on multidisciplinary clinical teams, so recovery nutrition gains credibility through portions and sodium profiles that fit familiar eating patterns. The Japanese Association of Cardiac Rehabilitation documented 689 candidates in its July 2025 specialist instructor examination, including six registered dietitians among a broad clinical group. Post-angioplasty recovery nutrition sales in Japan are forecast to expand at 6.5% CAGR by 2036 reflecting clinician-led adoption. Imported formats face friction if serving sizes or instructions feel detached from local meals and rehabilitation practice. Companies entering Japan need stronger professional alignment than firms relying mainly on consumer convenience in other profiled markets.

Who are the notable companies in the Post-Angioplasty Recovery Nutrition Market?

Abbott, Nestlé Health Science, Danone Nutricia, Mom's Meals (PurFoods), Step One Foods, ModifyHealth, Fresenius Kabi and Medtrition are the notable companies profiled in this market.

Clinical formulas, prepared meals and modular nutrition reach post-angioplasty patients through different care channels. Abbott, Nestlé Health Science and Danone Nutricia bring broad hospital-linked portfolios while Mom's Meals and ModifyHealth use payer-supported home delivery. Fresenius Kabi brings enteral nutrition into specialist channels, while entry barriers depend on clinical fit and reliable home fulfillment.

• Broad clinical nutrition platforms include Abbott and Fresenius Kabi, with adult formulas plus organized-care reach. Nestlé Health Science and Danone Nutricia bring medical nutrition portfolios, while Fresenius Kabi's parenteral nutrition expertise raises technical expectations.
• Mom's Meals (PurFoods) and ModifyHealth use payer-linked meals plus dietitian support to carry chronic-condition nutrition into home settings following clinical referral.
• Cardiometabolic and modular specialists include Step One Foods and Medtrition with narrower portfolios for defined clinical needs. Medtrition also serves wound-healing nutrition with documented modular protocols for clinical use.

Competitive Benchmarking: Post-Angioplasty Recovery Nutrition Market

Company	Nutrition Format Breadth	Cardiometabolic Specificity	Provider/Payer Access	Geographic Reach
Abbott	Medium	High	Medium	Global
Nestlé Health Science	High	High	Medium	Global
Danone Nutricia	High	High	High	Global
Mom's Meals (PurFoods)	High	High	High	United States
Step One Foods	Low	High	Medium	United States
ModifyHealth	Medium	High	High	United States
Fresenius Kabi	High	Low	Medium	Global
Medtrition	Medium	Low	Medium	United States

High nutrition-format breadth requires three verified routes while Medium requires two and Low identifies one documented route. High cardiometabolic specificity requires multiple heart or metabolic programs while Medium requires one such program. Low identifies a broader clinical focus without a cardiometabolic-specific program in official evidence. High provider or payer access requires multiple organized-care channels while Medium requires one documented route and Low would indicate direct-purchase access only.

Key Developments in the Post-Angioplasty Recovery Nutrition Market

• In November 2025, Nestlé Health Science began a BOOST collaboration with the American Diabetes Association focused on diabetes detection and adult nutrition education.
• In September 2025, ModifyHealth expanded in-network partnerships with major insurers for nationwide dietitian support beside condition-specific medically tailored meals serving chronic conditions including heart disease.
• In January 2025, Fresenius Kabi renewed its ESICM collaboration covering clinical-nutrition research awards plus professional education and international fellowships.

Key Players in the Post-Angioplasty Recovery Nutrition Market

Clinical Nutrition Platforms

• Abbott
• Nestlé Health Science
• Danone Nutricia

Home-Based Food and Cardiometabolic Programs

• Mom's Meals (PurFoods)
• Step One Foods
• ModifyHealth

Specialist Clinical Nutrition Suppliers

• Fresenius Kabi
• Medtrition

Post-Angioplasty Recovery Nutrition Market - Report Scope

Coverage field	Report scope
Market breakdown	By product type, phase, product form, end user, sales channel and region.
Quantitative Units	USD million.
Market Definition	Commercial nutrition products and meal programs used to support dietary recovery after angioplasty within secondary-prevention and rehabilitation pathways.
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa.
Countries Covered	South Korea, USA, UK, Germany, Japan, and 20+ countries included in the full report.
Key Companies Profiled	Abbott, Nestlé Health Science, Danone Nutricia, Mom's Meals (PurFoods), Step One Foods, ModifyHealth, Fresenius Kabi, Medtrition.
Forecast Period	2026 to 2036.
Approach	Primary and secondary research with market triangulation.

Post-Angioplasty Recovery Nutrition Market - Research Methodology

Method	Approach
Primary Research	FMI analysts gathered input from manufacturers, service providers, technology developers, distributors, end users, procurement teams, and subject-matter experts. Interviews examined purchasing decisions, product or service evaluation, adoption barriers, approval requirements, pricing considerations, and expectations for technical or commercial support. Respondents were also asked what evidence is required before a trial, pilot, or initial order develops into regular purchasing.
Desk Research	Desk research covered government statistics, regulatory publications, trade data, industry associations, technical literature, standards, company filings, product information, and official corporate announcements. Sources were reviewed for relevance, publication date, geographic coverage, and consistency with the defined market scope. Claims relating to performance, applications, approvals, capacity, investment, and commercial activity were retained only when supported by credible public evidence.
Market Sizing and Forecasting	The market model combined the baseline value with historical performance, segment structure, pricing and volume indicators, adoption levels, company participation, and country-level demand conditions. Forecast assumptions considered economic activity, investment trends, regulatory developments, technology adoption, purchasing cycles, supply availability, and barriers to wider market use. Segment and regional estimates were reconciled before the final market total was calculated.
Data Validation	Estimates were checked against multiple independent indicators, including public data, company activity, trade patterns, industry developments, and findings from primary interviews. Validation also tested whether products, services, applications, and company revenues fell within the defined market boundaries. Adjacent categories, unsupported claims, overlapping revenues, and activities without direct market relevance were excluded to reduce double counting and maintain consistency across segments and countries.

Post-Angioplasty Recovery Nutrition Market by Segments

Post-Angioplasty Recovery Nutrition Market segmented by Product Type:

• Cardiac Recovery ONS
• Low-Sodium Discharge Meal Kits
• Omega-3 & Polyphenol Support
• Others

Post-Angioplasty Recovery Nutrition Market segmented by Phase:

• 0-30 Days Post-Procedure
• 1-6 Months
• Long-Term Secondary Prevention

Post-Angioplasty Recovery Nutrition Market segmented by Product Form:

• Prepared Meals
• RTD ONS
• Supplements
• Others

Post-Angioplasty Recovery Nutrition Market segmented by End User:

• Homecare
• Cardiac Rehab Centers
• Hospitals
• Others

Post-Angioplasty Recovery Nutrition Market segmented by Sales Channel:

• Hospital Pharmacy
• Retail Pharmacy
• Online
• Institutional Tender
• Others

Post-Angioplasty Recovery Nutrition Market by Region:

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

• Danone. (2025, July 1). Danone completes the acquisition of Kate Farms, enhancing its USA specialized nutrition offerings.
• British Heart Foundation. (2025, July 11). Cardiac rehab: Poster on wards boost uptake.
• Abbott. (2026, May 13). Abbott launches Ensure Strength Pro in India to support healthy ageing.
• American Heart Association. (2025, February 27). ACC, AHA Issue New Acute Coronary Syndromes Guideline.
• Mom's Meals. (2026, June 18). Mom's Meals and Agilix Health Collaborate to Advance Food as Medicine.
• Brown, T. (2026, April 21). JCRP Line-Up: March/April 2026.
• American College of Cardiology. (2025, March 1). Journal Wrap | CVD Polypill, Digital Twins, More.
• American Heart Association. (2025, September 22). Psychological distress common after a heart attack, may lead to future heart conditions.
• Medtrition. (2025, October 27). MEDTRITION®, INC. LAUNCHES NUTRICONNECT™ - A PORTFOLIO BRAND FOR PERSONALIZED MODULAR NUTRITION.
• Korea Disease Control and Prevention Agency. (2025, December 30).
• American College of Cardiology. (2025, December 1). Feature | Maximizing Recovery: Cardiac Rehab in Contemporary CV Care.
• National Audit of Cardiac Rehabilitation. (2026, March). Quality and Outcomes Report 2025.
• Deutsche Rentenversicherung. (2025, October 1). Zuzahlung bei Rehabilitation.
• Japanese Association of Cardiac Rehabilitation. (2025, July 21).
• Nestlé Health Science. (2025, November 20). BOOST® Nutritional Drinks Teams Up with the American Diabetes Association® to Promote Early Detection of Diabetes and Highlight the Importance of Nutrition for Adults.
• ModifyHealth. (2025, September 4). ModifyHealth Expands Its In-Network Coverage, Strengthening Its Position as One of the Nation’s Largest Providers of Insurance-Covered Virtual Dietitian Support.
• Fresenius Kabi. (2025, January 29). Fresenius Kabi and ESICM Renew Joint Collaboration for 2025.
• Abbott. (2025, November 13). Abbott Launches New and Advanced Ensure Diabetes Care, A Clinically Proven Formula to Help Manage Blood Sugar.
• Nestlé Health Science. (2025, October 27). Nestlé Health Science and University of California, Davis Innovation Institute for Food & Health Announce Strategic Partnership to Accelerate Innovation in Nutrition and Health Science.
• Danone. (2025, June 25). Danone further invests in gut health and next-generation biotic research with the acquisition of The Akkermansia Company.
• Klodas, E. (2026, April 18). Bringing Something Savory to Step One Foods - The Right Way.
• ModifyHealth. (2025, July 1). ModifyHealth and Monash University Expand Partnership to Advance Low-FODMAP Diet Awareness in the USA
• Medtrition. (2025, July 9). PRESS RELEASE: EXPEDITE GRAPE PRODUCT LAUNCH.
• Kate Farms. (2026, July 28). Kate Farms Expands High Protein Nutrition Shake Into Walmart and CVS as Retail Distribution Grows Sevenfold.
• Fresenius Kabi. (2025, June 26). New R&D center in India strengthens Fresenius Kabi’s innovation network.
• Nestlé Health Science. (2025, October 17). Nestlé Health Science and the Food & Nutrition Innovation Institute at the Friedman School at Tufts University Expand Opportunities to Advance Nutrition Science and Innovation.
• Danone. (2025, September 29). Danone Inaugurates its OneBiome Laboratory in Paris-Saclay, Strengthening its Investment in Science-Driven Gut Health innovation.
• Fresenius Kabi. (2025, September 15). JUMPstart Clinical Nutrition Award winner announced at ESPEN congress.
• Kate Farms. (2025, July 8). Kate Farms unveils new High Protein Nutrition Shake: Protein with purpose, built for real change.
• Umoja Health. (2026, August 4). New Partnership Brings Medically Tailored Meals and Grocery Boxes to Eligible Medicaid Members in Oswego County.

This bibliography is provided for reader reference and is not exhaustive. The full report contains the complete reference list and detailed citations

This Report Answers

• What are the 2026 and 2036 values for the post-angioplasty recovery nutrition market?
• Which discharge conditions support demand for structured nutrition after angioplasty?
• Why does cardiac recovery ONS lead the product type category?
• Why does the 0-30 days post-procedure phase lead the phase category?
• Why do prepared meals lead the product form category?
• How do country growth profiles differ across South Korea, USA, UK, Germany and Japan?
• Which companies serve clinical nutrition, prepared-meal and cardiometabolic recovery routes?
• What limits conversion from rehabilitation guidance into paid nutrition purchasing?
• How can homecare extend a discharge recommendation into repeat nutrition use?